Literature DB >> 28708953

Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.

Andrea Orsi1,2, Giuseppina Maria Elena Colomba3, Fanny Pojero3, Giuseppe Calamusa3, Cristiano Alicino1, Cecilia Trucchi1, Paola Canepa1, Filippo Ansaldi1,2, Francesco Vitale3,4, Fabio Tramuto3,4.   

Abstract

Influenza A and B viruses are responsible for respiratory infections, representing globally seasonal threats to human health. The 2 viral types often co-circulate and influenza B plays an important role in the spread of infection. A 6-year retrospective surveillance study was conducted between 2010 and 2016 in 2 large administrative regions of Italy, located in the north (Liguria) and in the south (Sicily) of the country, to describe the burden and epidemiology of both B/Victoria and B/Yamagata lineages in different healthcare settings. Influenza B viruses were detected in 5 of 6 seasonal outbreaks, exceeding influenza A during the season 2012-2013. Most of influenza B infections were found in children aged ≤ 14 y and significant differences were observed in the age-groups infected by the different lineages. B/Victoria strains prevailed in younger population than B/Yamagata, but also were more frequently found in the community setting. Conversely, B/Yamagata viruses were prevalent among hospitalized cases suggesting their potential role in the development of more severe disease. The relative proportions of viral lineages varied from year to year, resulting in different lineage-level mismatch for the B component of trivalent influenza vaccine. Our findings confirmed the need for continuous virological surveillance of seasonal epidemics and bring attention to the adoption of universal influenza immunization program in the childhood. The use of tetravalent vaccine formulations may be useful to improve the prevention and control of the influenza burden in general population.

Entities:  

Keywords:  B/Victoria; B/Yamagata; Influenza type B; community; hospital; lineage; vaccine-mismatch

Mesh:

Substances:

Year:  2017        PMID: 28708953      PMCID: PMC5861802          DOI: 10.1080/21645515.2017.1342907

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  50 in total

1.  Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season.

Authors:  Filippo Ansaldi; Pierlanfranco D'Agaro; Daniela De Florentiis; Simona Puzelli; Yi Pu Lin; Victoria Gregory; Michael Bennett; Isabella Donatelli; Roberto Gasparini; Pietro Crovari; Alan Hay; Cesare Campello
Journal:  J Med Virol       Date:  2003-07       Impact factor: 2.327

2.  Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005.

Authors:  Cheryl Cohen; Lone Simonsen; Jong-Won Kang; Mark Miller; Jo McAnerney; Lucille Blumberg; Barry Schoub; Shabir A Madhi; Cécile Viboud
Journal:  Clin Infect Dis       Date:  2010-11-11       Impact factor: 9.079

Review 3.  Global burden of influenza as a cause of cardiopulmonary morbidity and mortality.

Authors:  William A Fischer; Michelle Gong; Satish Bhagwanjee; Jonathan Sevransky
Journal:  Glob Heart       Date:  2014-10-31

Review 4.  The burden of influenza B: a structured literature review.

Authors:  W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

5.  Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave.

Authors:  A Gutiérrez-Pizarraya; P Pérez-Romero; R Alvarez; T A Aydillo; G Osorio-Gómez; C Milara-Ibáñez; M Sánchez; J Pachón; E Cordero
Journal:  J Infect       Date:  2012-07-20       Impact factor: 6.072

6.  Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism.

Authors:  R Nerome; Y Hiromoto; S Sugita; N Tanabe; M Ishida; M Matsumoto; S E Lindstrom; T Takahashi; K Nerome
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

7.  Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014.

Authors:  Xiang Yong Oong; Kim Tien Ng; Tommy Tsan-Yuk Lam; Yong Kek Pang; Kok Gan Chan; Nik Sherina Hanafi; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

8.  Burden of influenza in Germany: a retrospective claims database analysis for the influenza season 2012/2013.

Authors:  Jennifer Haas; Sebastian Braun; Peter Wutzler
Journal:  Eur J Health Econ       Date:  2015-07-05

9.  The Molecular Epidemiology and Evolutionary Dynamics of Influenza B Virus in Two Italian Regions during 2010-2015: The Experience of Sicily and Liguria.

Authors:  Fabio Tramuto; Andrea Orsi; Carmelo Massimo Maida; Claudio Costantino; Cecilia Trucchi; Cristiano Alicino; Francesco Vitale; Filippo Ansaldi
Journal:  Int J Mol Sci       Date:  2016-04-13       Impact factor: 5.923

10.  The impact of influenza-like illness in young children on their parents: a quality of life survey.

Authors:  Maria Yui Kwan Chow; Jiehui Kevin Yin; Leon Heron; Angela Morrow; Alexa Dierig; Robert Booy; Julie Leask
Journal:  Qual Life Res       Date:  2013-12-27       Impact factor: 4.147

View more
  11 in total

1.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

2.  100 years since the 1918 influenza pandemic.

Authors:  Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2018-03-04       Impact factor: 3.452

3.  Surveillance Data for Eight Consecutive Influenza Seasons in Sicily, Italy.

Authors:  Fabio Tramuto; Vincenzo Restivo; Claudio Costantino; Giuseppina Maria Elena Colomba; Carmelo Massimo Maida; Alessandra Casuccio; Francesco Vitale
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

4.  Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in China.

Authors:  Yuemei Hu; Ming Shao; Yuansheng Hu; Qi Liang; Ningning Jia; Kai Chu; Li Xu; Jing Li; Changgui Li; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2020-04-29       Impact factor: 3.452

5.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

6.  Epidemiology and Genetic Variability of Circulating Influenza B Viruses in Uruguay, 2012-2019.

Authors:  María José Rivas; Miguel Alegretti; Leticia Cóppola; Viviana Ramas; Héctor Chiparelli; Natalia Goñi
Journal:  Microorganisms       Date:  2020-04-19

7.  Epidemiology of Respiratory Pathogens among Elderly Nursing Home Residents with Acute Respiratory Infections in Corsica, France, 2013-2017.

Authors:  Shirley Masse; Lisandru Capai; Alessandra Falchi
Journal:  Biomed Res Int       Date:  2017-12-17       Impact factor: 3.411

Review 8.  Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza.

Authors:  Yvette N Lamb
Journal:  Drugs       Date:  2019-08       Impact factor: 9.546

9.  The Epidemiology and Burden of Influenza B/Victoria and B/Yamagata Lineages in Kenya, 2012-2016.

Authors:  Gideon O Emukule; Fredrick Otiato; Bryan O Nyawanda; Nancy A Otieno; Caroline A Ochieng; Linus K Ndegwa; Peter Muturi; Godfrey Bigogo; Jennifer R Verani; Philip M Muthoka; Elizabeth Hunsperger; Sandra S Chaves
Journal:  Open Forum Infect Dis       Date:  2019-09-30       Impact factor: 3.835

10.  The influenza season 2016/17 in Bucharest, Romania - surveillance data and clinical characteristics of patients with influenza-like illness admitted to a tertiary infectious diseases hospital.

Authors:  Anca Drăgănescu; Oana Săndulescu; Dragoş Florea; Ovidiu Vlaicu; Anca Streinu-Cercel; Dan Oţelea; Victoria Aramă; Monica Luminiţa Luminos; Adrian Streinu-Cercel; Maria Niţescu; Alina Ivanciuc; Rodica Bacruban; Daniela Piţigoi
Journal:  Braz J Infect Dis       Date:  2018-10-31       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.